Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

  1. Zonghan Dai1,
  2. Robert C. Quackenbush2,
  3. Kevin D. Courtney1,
  4. Matthew Grove1,
  5. David Cortez1,
  6. Gary W. Reuther1, and
  7. Ann Marie Pendergast1,3
  1. 1Department of Pharmacology and Cancer Biology and Division of Hematology-Oncology, 2Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710 USA

Abstract

Oncogenic forms of the Abl and Src tyrosine kinases trigger the destruction of the Abi proteins, a family of Abl-interacting proteins that antagonize the oncogenic potential of Abl after overexpression in fibroblasts. The destruction of the Abi proteins requires tyrosine kinase activity and is dependent on the ubiquitin–proteasome pathway. We show that degradation of the Abi proteins occurs through a Ras-independent pathway. Significantly, expression of the Abi proteins is lost in cell lines and bone marrow cells isolated from patients with aggressive Bcr–Abl-positive leukemias. These findings suggest that loss of Abi proteins may be a component in the progression of Bcr–Abl-positive leukemias and identify a novel pathway linking activated nonreceptor protein tyrosine kinases to the destruction of specific target proteins through the ubiquitin–proteasome pathway.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL pende014{at}mc.duke.edu; FAX (919) 681-7148.

    • Received February 25, 1998.
    • Accepted March 24, 1998.
| Table of Contents

Life Science Alliance